美国甲真菌病患者角鲨烯环氧化酶突变检测:管理启示
研究分析了美国15683例疑似甲真菌病患者的趾甲皮肤癣菌分离株,皮肤癣菌检出率为37.6%,其中红色毛癣菌复合群占88.3%,须癣毛癣菌复合群占11.2%。毛癣菌属总体角鲨烯环氧化酶突变率为3.7%,须癣毛癣菌复合群突变率4.3%高于红色毛癣菌复合群的3.6%。已鉴定出与特比萘芬敏感性降低相关的角鲨烯环氧化酶基因突变,医生应了解耐药风险因素并实施抗真菌药物管理。
要点
- 美国15683例疑似甲真菌病患者中皮肤癣菌检出率为37.6%。
- 毛癣菌属角鲨烯环氧化酶总体突变率为3.7%,须癣毛癣菌复合群为4.3%。
- 已鉴定出与特比萘芬敏感性降低相关的角鲨烯环氧化酶基因突变。
核心结论
- 在美国趾甲甲真菌病患者中鉴定出与特比萘芬敏感性降低相关的角鲨烯环氧化酶基因突变。
- 医生应了解耐药风险因素,并实施抗真菌药物管理,如对皮肤癣菌病和甲真菌病进行定向诊断和治疗。
研究设计与样本
- 研究分析了美国15683例疑似甲真菌病患者就诊于皮肤科医生和足病医生诊所的样本。
- 回顾临床信息,采用多重实时PCR检测皮肤癣菌种类及角鲨烯环氧化酶突变。
主要发现
- 皮肤癣菌检出频率为37.6%。
- 在毛癣菌属分离株中,88.3%为红色毛癣菌复合群,11.2%为须癣毛癣菌复合群。
- 年龄大于70岁个体须癣毛癣菌复合群感染率更高。
- 毛癣菌属总体突变率为3.7%,须癣毛癣菌复合群突变率4.3% vs 红色毛癣菌复合群3.6%。
- 常见突变为T1189C/Phe397Leu(34.5%)、T1306C/Phe415Ser(16.0%)和C1191A/Phe397Leu(11.0%)。
关键数值与推荐
- 皮肤癣菌检出频率为37.6%。
- 毛癣菌属中红色毛癣菌复合群占88.3%,须癣毛癣菌复合群占11.2%。
- 毛癣菌属总体角鲨烯环氧化酶突变率为3.7%,须癣毛癣菌复合群为4.3%,红色毛癣菌复合群为3.6%。
- 常见突变T1189C/Phe397Leu占34.5%,T1306C/Phe415Ser占16.0%,C1191A/Phe397Leu占11.0%。
临床怎么用
- 医生应了解耐药风险因素,并实施抗真菌药物管理,如对皮肤癣菌病和甲真菌病进行定向诊断和治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Resistance to oral terbinafine, the most commonly used antifungal to treat dermatophytosis and onychomycosis worldwide, is being increasingly reported. In this study, we aimed to investigate the species distribution and prevalence of squalene epoxidase mutations among toenail dermatophyte isolates. Samples from 15,683 patients suspected of onychomycosis visiting the offices of dermatologists and podiatrists in the United States were analyzed. Clinical information was reviewed, and dermatophyte species with or without squalene epoxidase mutations were detected using multiplex real-time PCRs. The frequency of dermatophytes was 37.6%; of isolates belonging to the Trichophyton genus, 88.3% were the T. rubrum complex, and 11.2% were the T. mentagrophytes complex. Individuals aged >70 years exhibited higher infection rates for the T. mentagrophytes complex. The overall mutation rate among Trichophyton spp. was 3.7%, with a higher mutation rate detected in the T. mentagrophytes complex (4.3 vs. 3.6%). Commonly detected mutations were T1189C/Phe397Leu (34.5%), T1306C/Phe415Ser (16.0%), and C1191A/Phe397Leu (11.0%). Squalene epoxidase gene mutations associated with decreased terbinafine susceptibility have been identified in United States patients with toenail onychomycosis. Physicians should be aware of the risk factors for resistance development and engage in antifungal stewardship practices such as directed diagnosis and treatment of dermatophytosis and onychomycosis.
引用
- Gupta AK, Cooper EA, Wang T, et al. Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management. J Invest Dermatol. 2023. PMID: 37236595. doi:10.1016/j.jid.2023.04.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。